Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Oligonucleotide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 717,733Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Oligonucleotides: EMA drafts new guideline on manufacturing and development
    Oligonucleotides: EMA drafts new guideline on manufacturing and development

    23 Jul 2024

    // RAPS

    https://www.raps.org/news-and-articles/news-articles/2024/7/oligonucleotides-ema-drafts-new-guideline-on-manuf

    RAPS
    23 Jul 2024
    Share Share
    Aurorium Launches Haelium™ Pharmaceutical Solutions
    Aurorium Launches Haelium™ Pharmaceutical Solutions

    25 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240625009880/en

    BUSINESSWIRE
    25 Jun 2024
    Share Share
    Avidity Biosciences Closes Upsized Public Offering Of Common Stock
    Avidity Biosciences Closes Upsized Public Offering Of Common Stock

    17 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/avidity-biosciences-inc-announces-closing-of-upsized-public-offering-of-common-stock-including-full-exercise-of-underwriters-option-to-purchase-additional-shares-302174637.html

    PR NEWSWIRE
    17 Jun 2024
    Share Share
    Sirnaomics Demonstrates Antitumor Activity Of Novel Conjugate
    Sirnaomics Demonstrates Antitumor Activity Of Novel Conjugate

    12 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sirnaomics-demonstrates-strong-antitumor-activity-of-its-novel-oligonucleotide-chemodrug-conjugate-in-journal-of-oncology-research-and-therapy-302171871.html

    PR NEWSWIRE
    12 Jun 2024
    Share Share
    PepGen Announces Executive Team Promotions
    PepGen Announces Executive Team Promotions

    11 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240611396164/en

    BUSINESSWIRE
    11 Jun 2024
    Share Share
    GSK acquires oligonucleotide drug startup Elsie
    GSK acquires oligonucleotide drug startup Elsie

    07 Jun 2024

    // Delilah Alvarado BIOPHARMADIVE

    https://www.biopharmadive.com/news/gsk-acquire-elsie-oligonucleotides-rna-drug/718257/

    Delilah Alvarado BIOPHARMADIVE
    07 Jun 2024
    Share Share